»	Rebuilding immunoreceptors reveals their mode of activation

»	Basilea announces initiation of first isavuconazole study centers foreseen around year-end

»	Mycogen Seeds accelerates growth of U.S. corn business

»	Novartis announces Russian regulatory approval for Gilenya, a once-daily oral multiple sclerosis the...

»	Chiral Technologies Europe signs licensing agreement with the University of Vienna

»	Study of investigational agent abiraterone acetate for metastatic advanced prostate cancer unblinded...